Found 8 matching trials
Study That Tests AD109 in Patients Taking GLP-1 Drugs
PHASE2Phase 2 Safety, Efficacy and, Tolerability of Fixed Dose Combination of Aro...
Location
Pinnacle Research Group, LLC
Continuation Protocol for Obstructive Sleep Apnea (OSA)
PHASE3The combination drug composed of aroxybutynin and atomoxetine, designated A...
Status
Enrolling By Invitation
Location
Sleep Disorders Center of America
A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091
PHASE1Primary endpoint of this study is to evaluate the pharmacokinetic character...
Location
H+ Yangji Hospital
Crossover Trial of AD109 in Obstructive Sleep Apnea
PHASE2This is a randomized, 4-period, placebo-controlled, crossover, phase 2 clin...
Location
Preferred Research Partners, Inc.
AD109 Dose Finding in Mild to Moderate OSA
PHASE2This is a randomized, 3-period, placebo-controlled, crossover, phase 2 clin...
Location
Pacific Research Network
Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
PHASE3This is a Phase 3 Randomized Double-Blind Placebo-Controlled 6-month Parall...
Location
Alabama Neurology & Sleep Medicine
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
PHASE2This is a phase 2 randomized double-blind placebo-controlled parallel-arm d...
Location
Santa Monica Clinical Trials
Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
PHASE3This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Paralle...
Location
Sleep Disorders Center of Alabama